tiprankstipranks
Enlivex Therapeutics Ltd (IL:ENLV)
TASE:ENLV
Israel Market

Enlivex (ENLV) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
1Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Enlivex Therapeutics Ltd’s (ENLV) Moving Averages Convergence Divergence (MACD) indicator is -12.91, suggesting Enlivex Therapeutics Ltd is a Buy.
Enlivex Therapeutics Ltd’s (ENLV) 20-Day exponential moving average is 320.79, while Enlivex Therapeutics Ltd’s (ENLV) share price is 290.7, making it a Sell.
Enlivex Therapeutics Ltd’s (ENLV) 50-Day exponential moving average is 327.65, while Enlivex Therapeutics Ltd’s (ENLV) share price is 290.7, making it a Sell.

Enlivex (ENLV) Pivot Points

Apr 11, 2026, 05:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
259.20
270.10
277.10
288.00
295.00
305.90
312.90
Fibonacci
270.10
276.94
281.16
288.00
294.84
299.06
305.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enlivex (ENLV) Moving Averages

Apr 11, 2026, 05:13 PM
Period
Simple
Exponential
MA5
290.48Buy
295.39Sell
MA10
315.68Sell
307.76Sell
MA20
328.30Sell
320.79Sell
MA50
338.58Sell
327.65Sell
MA100
318.58Sell
329.88Sell
MA200
352.94Sell
348.85Sell
Enlivex Therapeutics Ltd’s (ENLV) 10-Day exponential moving average is 307.76, while Enlivex Therapeutics Ltd’s (ENLV) share price is 290.7, making it a Sell.
Enlivex Therapeutics Ltd’s (ENLV) 100-Day exponential moving average is 329.88, while Enlivex Therapeutics Ltd’s (ENLV) share price is 290.7, making it a Sell.
Enlivex Therapeutics Ltd’s (ENLV) stock price is 290.7 and Enlivex Therapeutics Ltd’s (ENLV) 50-day simple moving average is 338.58, creating a Sell signal.
Enlivex Therapeutics Ltd’s (ENLV) stock price is 290.7 and Enlivex Therapeutics Ltd’s (ENLV) 100-day simple moving average is 318.58, creating a Sell signal.
Enlivex Therapeutics Ltd’s (ENLV) stock price is 290.7 and Enlivex Therapeutics Ltd’s (ENLV) 200-day simple moving average is 352.94, creating a Sell signal.

Enlivex (ENLV) Technical Indicators

Apr 11, 2026, 05:13 PM
Name
Value
Implied Action
RSI (14)
39.62
Neutral
STOCH (9,6)
4.87
Buy
STOCHRSI (14)
4.87
Buy
MACD (12,26)
-12.91
Buy
ADX (14)
17.55
Buy
Williams %R
-92.22
Buy
CCI (14)
-133.71
Buy
ATR (14)
26.47
-
Ultimate Oscillator
29.92
Sell
ROC
-12.81
Sell
Enlivex Therapeutics Ltd’s (ENLV) Relative Strength Index (RSI) is 39.62, creating a Neutral signal.
Enlivex Therapeutics Ltd’s (ENLV) Trend Strength Indicator (ADX) is 17.55, creating a Buy signal.
Enlivex Therapeutics Ltd’s (ENLV) Commodity Channel Index (CCI) is -133.71, creating a Buy signal.
Enlivex Therapeutics Ltd’s (ENLV) Price Rate of Change (ROC) is -12.81, creating a Sell signal.

FAQ

Is ENLV a Buy, Hold, or Sell?
Based on ENLV’s technical indicators, ENLV is a Sell.
    What is ENLV’s RSI (14)?
    ENLV’s RSI (14) is 39.62, which suggests ENLV is a Neutral.
      What is ENLV’s MACD?
      ENLV’s MACD is -12.91, which suggests ENLV is a Buy.
        What is ENLV’s 5-day moving average?
        ENLV’s 5-day moving average is 290.48, which suggests ENLV is a Buy.
          What is ENLV’s 20-day moving average?
          ENLV 20-day moving average is 328.30, which suggests ENLV is a Sell.
            What is ENLV’s 50-day moving average?
            ENLV’s 50-day moving average is 338.58, which suggests ENLV is a Sell.
              What is ENLV’s 200-day moving average?
              ENLV’s 200-day moving average is 352.94, which suggests ENLV is a Sell.
                What is ENLV’s Williams % R (14)?
                ENLV’s Williams % R (14) is -92.22, which suggests ENLV is a Buy.
                  What is ENLV’s CCI (14)?
                  ENLV’s CCI (14) is -133.71, which suggests ENLV is a Buy.
                    What is the share price of Enlivex Therapeutics Ltd?